Media Coverage Archive 2018

Media Coverage

Media Coverage Archive 2018

This page contains a listing of news items featuring Fred Hutch.  Older items may be located in the archive to the left.

NBCDFW, Jan. 18, 2018
Hutch researchers Dr. Irwin Bernstein and Dr. Soheil Meshinchi talked about a drug developed at Fred Hutch. Mylotarg made its debut in 2000, but was taken off the market 10 years later. Now it’s back, and patients with a certain form of acute myeloid leukemia are showing a 35 to 40 percent increase in survival.
The Cancer Letter, Jan. 12, 2018
In a tribute, Dr. Gary Gilliland talked about working with Dr. Robert W. Day and the last accomplishments the former president made, including moving the Fred Hutch campus to its current location in South Lake Union.
The Atlantic, Jan. 12, 2018
Biologist Dr. Harmit Malik, of the Fred Hutch Basic Sciences Division, was quoted in a story in The Atlantic about Arc, a difficult-to-study gene that looks like a virus and influences learning and memory, apparently by helping neurons share genetic information among themselves.
Reuters, Jan. 9, 2018
Commenting on a study about racial and socioeconomic health care disparities among elderly patients with lung cancer, Fred Hutch’s Dr. Veena Shankaran said cultural and community beliefs may play a role in treatment decisions, but “many studies have shown that black patients have less access to cancer care and worse cancer outcomes than whites.”
Seattle Times, Jan. 4, 2018
Microsoft will partner with Adaptive Biotechnologies, which was formed in 2009 with Fred Hutch technology, to develop blood tests that will “alert doctors when people are fighting specific diseases.
STAT, Jan. 1, 2018
Hutch epidemiologist Dr. Noel Weiss commented on a recent article in Annals of Internal Medicine suggesting that too much screening for certain cancers can skew our view of risk factors.
ASH Clinical News, Jan. 1, 2018
In an American Society of Hematology Q&A, Hutch president and director Dr. Gary Gilliland talks about the people and events that inspired him to become a doctor and specialize in hematology.
KIRO-TV, Jan. 1, 2018
In a story featuring Bridgette Hempstead, founder of the Cierra Sisters, a support group for black women with breast cancer, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, said there is a common and false misconception that nothing can be done about a breast cancer diagnosis.